Loading clinical trials...
Loading clinical trials...
THE Actuate-CBC Study: Accelerating the Uptake of Telemedicine for Crisis Burn Care
The study team will use implementation science to accelerate the uptake of teleconsultationfor burn patients by 1) examining the relationships between clinician perceptions of acceptability, feasibility, intention to use, and actual use of burn teleconsultation 2) identifying the optimal process for burn teleconsultation and the barriers and facilitators for its use during a crisis or prolonged care situation, and 3) designing and testing the effectiveness of a specific, tailored burn teleconsultation toolkit intervention to increase burn teleconsultation use.
The principal investigator's central hypothesis is that a tailored implementation intervention (toolkit) that integrates the known advantages of using telemedicine for burn consultation with new knowledge regarding clinician perceptions and the setting in which they work will improve the feasibility, acceptance, intention to use, and uptake of burn teleconsultation. The implementation intervention will enable rapid burn teleconsultation implementation under crisis circumstances and assist clinicians to virtually connect the person caring for a burn patient anywhere to the entire burn team's expertise. The study results will lead to more robust national crisis, wartime, and disaster response plans, improve quality of burn care, and decrease morbidity and mortality from serious burn injury, regardless of injury location.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UCI Health Regional Burn Center
Orange, California, United States
Massachusetts General Hospital Sumner Redstone Burn Center
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Regions Hospital Burn Center
Saint Paul, Minnesota, United States
Start Date
January 4, 2023
Primary Completion Date
June 30, 2026
Completion Date
June 15, 2027
Last Updated
July 30, 2025
2,183
ESTIMATED participants
Tool kit
BEHAVIORAL
Lead Sponsor
University of Pennsylvania
NCT05480930
NCT06890169
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions